Project Details
Description
A Phase 1 Open-Label Dose Escalation Study to Evaluate the Safety and Efficacy of HMI-203 in ERTTreated Adults with Mucopolysaccharidosis Type II (MPS II) (juMPStart Trial)
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/22 → 12/31/23 |
Funding
- HOMOLOGY MEDICINES INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.